Octagon Capital Advisors LP Insmed Inc Transaction History
Octagon Capital Advisors LP
- $449 Million
- Q4 2024
A detailed history of Octagon Capital Advisors LP transactions in Insmed Inc stock. As of the latest transaction made, Octagon Capital Advisors LP holds 250,000 shares of INSM stock, worth $18.8 Million. This represents 3.85% of its overall portfolio holdings.
Number of Shares
250,000
Previous 250,000
-0.0%
Holding current value
$18.8 Million
Previous $18.3 Million
5.42%
% of portfolio
3.85%
Previous 4.41%
Shares
6 transactions
Others Institutions Holding INSM
# of Institutions
498Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.37 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.07 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$973 Million84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$954 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$534 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.2B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...